Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 11, 2023

BUY
$57.77 - $65.93 $808 - $923
14 New
14 $0
Q3 2020

Oct 13, 2020

SELL
$85.07 - $109.69 $255 - $329
-3 Closed
0 $0
Q1 2020

Apr 10, 2020

BUY
$63.18 - $85.97 $189 - $257
3 New
3 $0

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Perkins Coie Trust CO Portfolio

Follow Perkins Coie Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Coie Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Coie Trust CO with notifications on news.